InnumeSensor virus cell background

Our Science

Efficacy Study of IMSA101 in Combination with Radiation and Checkpoint Inhibitors in Patients with Oligoprogressive (OPD) and Oligometastatic (OMD) Solid Tumor Malignancies

doctor and patient reviewing information on tablet

For more information on the ongoing trial, please visit clinicaltrials.gov.